260 related articles for article (PubMed ID: 29099504)
21. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature.
Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N
J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373
[TBL] [Abstract][Full Text] [Related]
22. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
23. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
24. Atypical Fibroxanthoma.
López L; Vélez R
Arch Pathol Lab Med; 2016 Apr; 140(4):376-9. PubMed ID: 27028396
[TBL] [Abstract][Full Text] [Related]
25. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
[TBL] [Abstract][Full Text] [Related]
26. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
27. Somatic Mutation Profile of Atypical Fibroxanthoma and Cutaneous Undifferentiated Pleomorphic Sarcoma.
Lim YH; Zaki TD; Levinsohn JL; Galan A; Choate KA; Hanlon AM
Dermatol Surg; 2021 Feb; 47(2):290-292. PubMed ID: 32079866
[No Abstract] [Full Text] [Related]
28. Pleomorphic Dermal Sarcoma With Metastasis to the Lung: A Case Report.
Shafi S; Bechtel M; Contreras CM; Plaza JA
Am J Dermatopathol; 2023 Oct; 45(10):708-711. PubMed ID: 37335842
[TBL] [Abstract][Full Text] [Related]
29. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS).
Helbig D; Ziemer M; Dippel E; Erdmann M; Hillen U; Leiter U; Mentzel T; Osterhoff G; Ugurel S; Utikal J; von Bubnoff D; Weishaupt C; Grabbe S
J Dtsch Dermatol Ges; 2022 Feb; 20(2):235-243. PubMed ID: 35099104
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
31. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma.
Mihic-Probst D; Zhao J; Saremaslani P; Baer A; Oehlschlegel C; Paredes B; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(1):19-26. PubMed ID: 15015571
[TBL] [Abstract][Full Text] [Related]
32. High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma.
Lynn M; Wang Y; Slater J; Shah N; Conroy J; Ennis S; Morris T; Betts DR; Fletcher JA; O'Sullivan MJ
Diagn Mol Pathol; 2013 Jun; 22(2):76-84. PubMed ID: 23628818
[TBL] [Abstract][Full Text] [Related]
33. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Xerri L; Adélaïde J; Popovici C; Garnier S; Guille A; Mescam-Mancini L; Laurent C; Brousset P; Coze C; Michel G; Chaffanet M; Bouabdallah R; Coso D; Bertucci F; Birnbaum D
Am J Surg Pathol; 2018 Feb; 42(2):150-159. PubMed ID: 29194093
[TBL] [Abstract][Full Text] [Related]
34. Upper extremity pleomorphic dermal sarcoma in a patient with chronic myelomonocytic leukemia.
Capizzello A; Tatsiou Z; Prassopoulos P
Hippokratia; 2019; 23(4):181-185. PubMed ID: 32742171
[TBL] [Abstract][Full Text] [Related]
35. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
[TBL] [Abstract][Full Text] [Related]
36. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
37. Pleomorphic Dermal Sarcoma: A Clinical and Histopathologic Emulator of Atypical Fibroxanthoma, but Different Biologic Behavior.
Carletti M; Nguyen DA; Malouf P; Ingersoll Z; Hosler GA; Weis SE
HCA Healthc J Med; 2022; 3(5):299-304. PubMed ID: 37425251
[TBL] [Abstract][Full Text] [Related]
38. Spindle Cell/Pleomorphic Lipoma With Trichodiscoma-like Epithelial Hyperplasia Mimicking Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma.
Aghighi M; Andea AA; Patel RM; Fullen DR; Bresler SC
Am J Dermatopathol; 2022 Oct; 44(10):764-767. PubMed ID: 35503875
[TBL] [Abstract][Full Text] [Related]
39. Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp.
Zeller J; Kiefer J; Braig D; Winninger O; Kraus D; Hagelstein S; Eisenhardt SU
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740535
[TBL] [Abstract][Full Text] [Related]
40.
Gong XY; Chen HB; Zhang LQ; Chen DS; Li W; Chen DH; Xu J; Zhou H; Zhao LL; Song YJ; Xiao MZ; Deng WL; Qi C; Wang XR; Chen X
Front Immunol; 2022; 13():920253. PubMed ID: 35911687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]